Charles River Laboratories International (CRL) Other financing activities (2009 - 2026)

Charles River Laboratories International has reported Other financing activities for 18 years, with the latest figure at -$607000.0 in Q2 2026.

• On a quarterly basis, Other financing activities rose 90.6% year-over-year to -$607000.0 in Q2 2026; TTM through Jun 2026 was -$10.2 million, a 83.11% increase from a year earlier, with the FY2025 full-year figure at -$14.0 million, up 55.4% from the prior year.
• Other financing activities was -$607000.0 for Q2 2026 at Charles River Laboratories International, up from -$2.0 million in the prior quarter.
• The five-year high for Other financing activities was $35.1 million in Q3 2022, with the low at -$49.2 million in Q3 2024.
• Average Other financing activities over 5 years is $155058.8, with a median of $826000.0 recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Other financing activities surged 582.11% in 2022, then slumped 1349.83% in 2024.
• Over 5 years, Other financing activities stood at $7.4 million in 2022, then retreated by 19.74% to $5.9 million in 2023, then plunged by 176.48% to -$4.5 million in 2024, then jumped by 70.61% to -$1.3 million in 2025, then surged by 54.53% to -$607000.0 in 2026.
• The last three Other financing activities figures came in at -$607000.0 (Q2 2026), -$2.0 million (Q1 2026), and -$1.3 million (Q4 2025), per Business Quant data.